Copyright © 1999 by the European Society of Cardiology.
Editorial
New interventions for obstructive hypertrophic cardiomyopathy: promise and prudence
a Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, U.S.A.
1999
References
- Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997;350:127133[CrossRef][Web of Science][Medline]
- Gietzen FH, Leuner ChJ, Raute-Kreinsen U. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic cardiomyopathy. Eur Heart J. 1999;20:13421354
[Abstract/Free Full Text] - Knight C, Kurbaan AS, Seggewiss H. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy. Outcome in the first series of patients. Circulation. 1997;95:20752081
[Abstract/Free Full Text] - Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 30 month follow-up in 25 patients. J Am Coll Cardiol. 1993;31:252258
- Lakkis NM, Nagueh SF, Kleiman NS. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 1998;98:17501755
[Abstract/Free Full Text] - Spirito P, Maron BJ. Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1999;33:10711075
[Free Full Text]
This article has been cited by other articles:
![]() |
B. J. Maron, J. A. Dearani, S. R. Ommen, M. S. Maron, H. V. Schaff, B. J. Gersh, and R. A. Nishimura The case for surgery in obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2044 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
F H Gietzen, C J Leuner, L Obergassel, C Strunk-Mueller, and H Kuhn Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients Heart, June 1, 2004; 90(6): 638 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Gietzen, C. J. Leuner, L. Obergassel, C. Strunk-Mueller, and H. Kuhn Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions Circulation, July 23, 2002; 106(4): 454 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Faber Acute and long-term results after TASH Eur. Heart J., April 1, 2000; 21(7): 590 - 591. [PDF] |
||||
![]() |
F.H. Gietzen, CH.J. Leuner, J. Hegselmann, C. Strunk-Mueller, and H. Khun A reply Eur. Heart J., April 1, 2000; 21(7): 591 - 593. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



